Optimizing Pain Management Following Laparoscopic Cholecystectomy RCT

NCT ID: NCT05214157

Last Updated: 2022-01-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

804 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-03-20

Study Completion Date

2022-01-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

evaluating the two final steps we added to optimize post laparoscopic cholecystectomy pain management.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Introduction: After a laparoscopic cholecystectomy (LC), pain is still a significant concern, leading to extended hospital stays or readmissions. In majority of patients, postoperative pain medications are required. A standardized strategy is needed to offer effective pain relief postoperatively. The majority of pain in the early postoperative period is due to elimination of intraperitoneal surface tension or of parietal type. Aim of the work: to evaluate the two final steps we added to optimize postoperative pain management. Patients and methods: Over the period from March 2020 to December 2021, 816 patients with gallbladder stone undergoing LC were randomized into 2 groups after exclusion of 12 patients: Group A; interventional contained 402 patients. Group B; control contained 402 patients. Post-operative data to be compared were made in terms of operative time, shoulder pain, upper abdominal pain, (at 6,12,18 and 24 hours) and number of analgesic doses and hospital stay. Pain intensity was assessed by using the visual analogue scale (VAS) for each patient.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Post-operative Pain Cholecystectomy, Laparoscopic Pain Assessment Pain Intensity Pain Intensity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group A

interventional group, final two operative steps applied

Group Type EXPERIMENTAL

active gas aspiration

Intervention Type PROCEDURE

sucking remaining Co2 from the peritoneal cavity and local anaesthetic application at port sites

group B

control group

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

active gas aspiration

sucking remaining Co2 from the peritoneal cavity and local anaesthetic application at port sites

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

application of Bupivacaine soaked sponge

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who were having symptoms consistent with biliary colic,
* had ultrasound evidence of gall stones,
* classified as American Society of Anesthesiology (ASA) I and II
* ages ranging from 18 to 65 years

Exclusion Criteria

* Patients who refused to give consent,
* pregnant,
* had a history of drug abuse,
* had CBD stones,
* acute cholecystitis,
* acute pancreatitis,
* previous abdominal surgery,
* history of peritonitis,
* had carcinoma of the gall bladder Patients who were converted to open surgery,
* patients who required placement of drains
* patients with intraoperative complications (CBD injury or liver bed bleeding).
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zagazig University

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohamed lotfy

Associate professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

mohamed l ali, md

Role: STUDY_DIRECTOR

Zagazig University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zagazig University

Zagazig, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

zuh 243

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.